- Lomina's Divisions:
- Human Diagnostics
- Veterinary Diagnostics
Menu
Menu
The kit is used for the qualitative detection of new coronavirus nucleocapsid (N) antigen in human oropharyngeal and/or nasopharyngeal swab samples in vitro. It is used as a supplementary detection indicator for suspected cases of new coronavirus. It cannot be used as the only basis for the diagnosis and exclusion of pneumonitis infected by new coronavirus.
The test is developed and tested ffor the use of nasopharyngeal or oropharyngeal samples.
Nasopharyngeal swab
Oropharyngeal swab
Sensitivity: 94,17% (95% CI: 87,75% – 97,83%)
Specificity: 100% (95% CI: 98,54% – 100%)
One band/line appears in the control region “C”, and another band/line appears in the “T” region (picture A).
Only one band/line appears in the control region “C” with no other bar sign elsewhere (picture B).
No band/line appears in the control region (C), whether a test band “T” is present or not. Repeat invalid tests with a new sample, new test device and reagent. Insufficient sample volume, inaccurate operating procedure or expired tests may yield an invalida result. Contact your local distributor if the problem continues. (picture C).
As a globally active European brand, we distribute our portfolio of products to an extensive network of our business partners’ brick-and-mortar shops and e-shops.
By registering to receive news, I give my consent to my data being processed by the Lomina Company and agree with the Personal Data Protection Principles. Provision of data is voluntary. I may withdraw my consent at any time.
